Parameter | Result |
---|---|
Male sex, n (%) | 12 (85.7) |
Age, median (IQR; years) | 41 (25–48) |
Type of EGID | EoE (n = 6) EGE (n = 1) EC (n = 7) |
Time since diagnosis, median (IQR; years) | EoE: 1 (0.25–1) EGE: 3 EC: 1.5 (1–4.5) |
Tissue eosinophils at diagnosis, median (IQR; n/HPF) | EoE: 64 (30–95) EGE: 114 EC: 100 (100–107) |
Blood eosinophils at diagnosis, median (IQR; cells/microL) | 300 (180–330) |
Serum ECP, median (IQR; U/mL) | 28 (11.0–62.7) (11/14) |
Main gastrointestinal symptoms at onset, n (%) | EoE: dysphagia, reflux, 4 (66.7) EGE: dyspepsia EC: abdominal pain, 5 (71.4) |
Allergic comorbidities and sensitization profile | |
Atopya, n (%) | 11 (78.5) |
Allergic rhinitis, n (%) | 10 (71.4) |
Asthma, n (%) | 2 (14.2) |
Atopic dermatitis, n (%) | 2 (14.2) |
Food allergy, n (%) | 5 (35.7) |
Drug allergy, n (%) | 2 (14.2) |
Hymenoptera venom allergy, n (%) | 1 (7.1) |
PR-10b, n (%) | 3 (21.3) |
LTPb, n (%) | 7 (50.0) |
Profilinb, n (%) | 2 (14.2) |
IgE level, median (IQR; kU/L) | 173 (112–417) |